| Keith Douglas Nord, MD | |
|
111 Stonebridge Blvd, Jackson, TN 38305-3830 | |
| (731) 427-7888 | |
| (731) 265-4159 |
| Full Name | Keith Douglas Nord |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 41 Years |
| Location | 111 Stonebridge Blvd, Jackson, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033180948 | NPI | - | NPPES |
| 3091423 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD0000026655 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Volunteer Home Care | Humboldt, TN | Home health agency |
| Amedisys Home Health Care | Jackson, TN | Home health agency |
| Extendicare Home Health Of West Tn | Jackson, TN | Home health agency |
| Volunteer Homecare Of West Tn | Parsons, TN | Home health agency |
| Jackson-madison County General Hospital | Jackson, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Privia Medical Group Tennessee Llc | 0547667552 | 71 |
| Noma Pc | 0840589255 | 7 |
News Archive
Heart disease patients enrolled in a clinical trial - designed to test whether a stronger dose of the influenza vaccine can prevent death or hospitalization due to a heart attack, heart failure, stroke or pneumonia - have begun receiving their first flu shots in Toronto and Boston.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has successfully produced a new VLP vaccine candidate for the H7N9 virus that is responsible for the current influenza outbreak in China.
Researchers from the University of S-o Paulo (USP) have identified an RNA known as INXS that, although containing no instructions for the production of a protein, modulates the action of an important gene in the process of apoptosis, or programmed cell death.
Direct contact and droplets are the primary ways influenza spreads. Under certain conditions, however, aerosol transmission is possible. In a study published in the current issue of Clinical Infectious Diseases, available online, the authors examined such an outbreak in their own hospital in Hong Kong.
› Verified 7 days ago
| Entity Name | Noma Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831550854 PECOS PAC ID: 0840589255 Enrollment ID: O20160524001185 |
News Archive
Heart disease patients enrolled in a clinical trial - designed to test whether a stronger dose of the influenza vaccine can prevent death or hospitalization due to a heart attack, heart failure, stroke or pneumonia - have begun receiving their first flu shots in Toronto and Boston.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has successfully produced a new VLP vaccine candidate for the H7N9 virus that is responsible for the current influenza outbreak in China.
Researchers from the University of S-o Paulo (USP) have identified an RNA known as INXS that, although containing no instructions for the production of a protein, modulates the action of an important gene in the process of apoptosis, or programmed cell death.
Direct contact and droplets are the primary ways influenza spreads. Under certain conditions, however, aerosol transmission is possible. In a study published in the current issue of Clinical Infectious Diseases, available online, the authors examined such an outbreak in their own hospital in Hong Kong.
› Verified 7 days ago
| Entity Name | Seven Springs Orthopaedics, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194210005 PECOS PAC ID: 2668725557 Enrollment ID: O20181023001041 |
News Archive
Heart disease patients enrolled in a clinical trial - designed to test whether a stronger dose of the influenza vaccine can prevent death or hospitalization due to a heart attack, heart failure, stroke or pneumonia - have begun receiving their first flu shots in Toronto and Boston.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has successfully produced a new VLP vaccine candidate for the H7N9 virus that is responsible for the current influenza outbreak in China.
Researchers from the University of S-o Paulo (USP) have identified an RNA known as INXS that, although containing no instructions for the production of a protein, modulates the action of an important gene in the process of apoptosis, or programmed cell death.
Direct contact and droplets are the primary ways influenza spreads. Under certain conditions, however, aerosol transmission is possible. In a study published in the current issue of Clinical Infectious Diseases, available online, the authors examined such an outbreak in their own hospital in Hong Kong.
› Verified 7 days ago
| Entity Name | Privia Medical Group Tennessee Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376110858 PECOS PAC ID: 0547667552 Enrollment ID: O20210917001131 |
News Archive
Heart disease patients enrolled in a clinical trial - designed to test whether a stronger dose of the influenza vaccine can prevent death or hospitalization due to a heart attack, heart failure, stroke or pneumonia - have begun receiving their first flu shots in Toronto and Boston.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has successfully produced a new VLP vaccine candidate for the H7N9 virus that is responsible for the current influenza outbreak in China.
Researchers from the University of S-o Paulo (USP) have identified an RNA known as INXS that, although containing no instructions for the production of a protein, modulates the action of an important gene in the process of apoptosis, or programmed cell death.
Direct contact and droplets are the primary ways influenza spreads. Under certain conditions, however, aerosol transmission is possible. In a study published in the current issue of Clinical Infectious Diseases, available online, the authors examined such an outbreak in their own hospital in Hong Kong.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Keith Douglas Nord, MD 111 Stonebridge Blvd, Jackson, TN 38305-3931 Ph: (731) 427-7888 | Keith Douglas Nord, MD 111 Stonebridge Blvd, Jackson, TN 38305-3830 Ph: (731) 427-7888 |
News Archive
Heart disease patients enrolled in a clinical trial - designed to test whether a stronger dose of the influenza vaccine can prevent death or hospitalization due to a heart attack, heart failure, stroke or pneumonia - have begun receiving their first flu shots in Toronto and Boston.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has successfully produced a new VLP vaccine candidate for the H7N9 virus that is responsible for the current influenza outbreak in China.
Researchers from the University of S-o Paulo (USP) have identified an RNA known as INXS that, although containing no instructions for the production of a protein, modulates the action of an important gene in the process of apoptosis, or programmed cell death.
Direct contact and droplets are the primary ways influenza spreads. Under certain conditions, however, aerosol transmission is possible. In a study published in the current issue of Clinical Infectious Diseases, available online, the authors examined such an outbreak in their own hospital in Hong Kong.
› Verified 7 days ago
John Patrick Masterson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 569 Skyline Dr, Suite 100, Jackson, TN 38301 Phone: 731-427-7888 Fax: 731-265-4152 | |
L David Johnson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Physicians Dr, Jackson, TN 38305 Phone: 731-661-9825 Fax: 731-668-6757 | |
William Stansul Ragon Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Physicians Dr, Jackson, TN 38305 Phone: 731-661-9825 Fax: 731-668-6757 | |
John E Everett, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 24 Physicians Dr, Jackson, TN 38063 Phone: 731-661-9825 Fax: 731-668-6757 | |
John Douglas Haltom Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Physicians Dr, Jackson, TN 38305 Phone: 731-661-9825 Fax: 731-668-6757 | |
Jason T Hutchison, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Physicians Dr, Jackson, TN 38305 Phone: 731-661-9825 Fax: 731-668-6757 |